Search Videos and More
Course
2027 Atlantic Regional Hematopathology Meeting:
Future Directions in Hematopathology
News
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Over more than two decades at Fox Chase Cancer Center, Chang Ming Charlie Ma, PhD, FAAPM, FASTRO, Professor, Director of Physics, and Vice Chair of Radiation Oncology, helped transform clinical physics from a behind-the-scenes discipline into a force that reshaped how radiation therapy is planned, calculated, and delivered.
News
Fox Chase Cancer Center at ASTRO 2026
We are pleased to highlight several Fox Chase–Temple sessions taking place at ASTRO 2026. Explore the sessions below as our faculty and residents share their work throughout the meeting — and be sure to visit us at Booth #1336 in the ASTRO Exhibit Hall.
News
Adaptive Radiation Boost for Rectal Cancer (ARBOR)
The goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer.
News
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.
News
Redefining Treatment Timelines for Platinum-Resistant Ovarian Cancer
“Integrating clinical trials and newer therapies earlier in a patient’s ovarian cancer treatment journey can make a significant difference in their outcome,” said Angela Jain, MD, Associate Professor, Department of Hematology/Oncology; Chief, Division of Gynecologic Medical Oncology; and Clinical Director of GYN/Well Women’s Health Clinical Service Line.
Course
Philadelphia Lung Cancer Symposium
Join us for the Philadelphia Lung Cancer Symposium, a dynamic, multidisciplinary education program featuring expert faculty from leading Philadelphia institutions, hosted by Fox Chase Cancer Center (FCCC) in collaboration with Penn Medicine’s Abramson Cancer Center. This full-day symposium—led by Program Directors Hossein Borghaei, DO, MS (FCCC) and Charu Aggarwal, MD, MS (Abramson Cancer Center)—delivers a high-impact review of evolving standards in early-stage disease, small cell lung cancer, targeted therapies, and emerging approaches shaping practice in 2026 and beyond.
News
Expanding the Role and Responsibilities of Urologic Advanced Practice Providers
Since 2024, the Fox Chase – Temple Urologic Institute has grown exponentially, increasing demand for highly trained advanced practice providers (APPs) to work alongside attending specialists. Recently, eight new APPs have joined the team to address the expanding clinical needs in both urologic oncology and general urology, with clinic appointments often exceeding capacity.
News
Two New Carol and Louis Della Penna Chairs at Fox Chase
Carol and Louis Della Penna are two of Fox Chase Cancer Center’s most generous and committed supporters. Recently, two esteemed urologists received the honor of an endowed chair:
News
Preserving Life and Quality of Life in Muscle-Invasive Bladder Cancer
Fox Chase-developed RETAIN clinical trials explore bladder preservation for selected patients
News
U.S. News & World Report Recognizes Fox Chase Cancer Center Among Nation’s Best Hospitals for Cancer Care
U.S. News & World Report has ranked Fox Chase Cancer Center among the nation’s top hospitals for cancer care according to the publication’s 2026-27 Best Hospitals rankings.
News
It Takes a Community for a Winn Scholar to Build a Clinical Trial
“My past experiences with Teach for America in North Philadelphia were a prologue to what I am doing now,” said Austin Williams, MD, MSEd, FACS, a surgical oncologist specializing in breast cancer at Fox Chase Cancer Center and Associate Program Director of the Breast Oncology Fellowship at Fox Chase.